STOCKHOLM, Sweden--(BUSINESS WIRE)--Regulatory News:
Elekta AB (STO:EKTA)
President & CEO Tomas Puusepp comments:
”In the second quarter of fiscal year 2007/08, we saw a continued strong demand. Order intake for the first 6 months increased by 12 percent in local currency, driven primarily by a continued success in radiation therapy in North America, a stronger interest in Leksell Gamma Knife® in Europe and a strong recovery on the Chinese market.
